Non-medical reverse switch between the originator infliximab and its biosimilar in patients with inflammatory bowel disease: clinical outcomes and therapeutic drug monitoring

被引：0
|
作者：
Gonczi, L. [1 ]
Ilias, A. [1 ]
Szanto, K. [2 ]
Kurti, Z. [1 ]
Golovics, P. A. [3 ]
Farkas, K. [2 ]
Schafer, E. [3 ]
Szepes, Z. [2 ]
Szalay, B. [4 ]
Vincze, A. [5 ]
Szamosi, T. [3 ]
Molnar, T. [2 ]
Lakatos, P. [6 ]
机构：
[1] Semmelweis Univ, Dept Internal Med 1, Budapest, Hungary
[2] Univ Szeged, Dept Med 1, Szeged, Hungary
[3] Mil Hosp, State Hlth Ctr, Dept Gastroenterol, Budapest, Hungary
[4] Semmelweis Univ, Dept Lab Med, Budapest, Hungary
[5] Univ Pecs, Dept Med 1, Pecs, Hungary
[6] McGill Univ, Div Gastroenterol, Hlth Ctr, Montreal, PQ, Canada
来源：
JOURNAL OF CROHNS & COLITIS | 2019年 / 13卷
关键词：
D O I：
10.1093/ecco-jcc/jjy222.533
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P409
引用
收藏
页码：S314 / S314
页数：1
相关论文
共 50 条
  • [21] Evaluating the nocebo effect in a non-medical switching program from originator to biosimilar infliximab in patients with inflammatory bowel disease: A real yet temporary phenomenon
    Dutt, K.
    Srinivasan, A.
    Van Langenberg, D.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 116 - 117
  • [22] Systematic review: effectiveness and safety of switching between originator infliximab and biosimilar infliximab in patients with inflammatory bowel disease
    Lichtenstein, Gary R.
    Soonasra, Arif
    Latymer, Mark
    Singh, Sheena
    Feagan, Brian G.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2024, 24 (07) : 691 - 708
  • [23] NON-MEDICAL SWITCHING FROM INFLIXIMAB TO A BIOSIMILAR IN ADOLESCENTS AND YOUNG ADULTS WITH INFLAMMATORY BOWEL DISEASE
    McNicol, Megan
    Abdel-Rasoul, Mahmoud
    Morris, Grant
    Boyle, Brendan
    Dotson, Jennifer
    Michel, Hilary
    Maltz, Ross
    GASTROENTEROLOGY, 2023, 164 (04) : S79 - S79
  • [24] NON-MEDICAL SWITCHING FROM INFLIXIMAB TO A BIOSIMILAR IN PEDIATRICS AND YOUNG ADULTS WITH INFLAMMATORY BOWEL DISEASE
    McNicol, Megan
    Abdel-Rasoul, Mahmoud
    Morris, Grant
    Boyle, Brendan M.
    Dotson, Jennifer L.
    Michel, Hilary K.
    Maltz, Ross
    GASTROENTEROLOGY, 2023, 164 (06) : S494 - S494
  • [25] NON-MEDICAL SWITCHING FROM INFLIXIMAB TO A BIOSIMILAR IN ADOLESCENTS AND YOUNG ADULTS WITH INFLAMMATORY BOWEL DISEASE
    McNicol, Megan
    Abdel-Rasoul, Mahmoud
    Morris, Grant
    Boyle, Brendan
    Dotson, Jennifer
    Michel, Hilary
    Maltz, Ross
    INFLAMMATORY BOWEL DISEASES, 2023, 29 : S62 - S62
  • [26] Non-medical switch between adalimumab biosimilars and from the originator adalimumab to biosimilars in inflammatory bowel disease patients - a multicentre study on efficacy and drug sustainability
    Lontai, L.
    Gonczi, L.
    Balogh, F.
    Komlodi, N.
    Resal, T.
    Farkas, K.
    Molnar, T.
    Golovics, P.
    Schafer, E.
    Szamosi, T.
    Miheller, P.
    Ilias, A.
    Lakatos, P. L.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I518 - I519
  • [27] NON-MEDICAL SWITCH BETWEEN ADALIMUMAB BIOSIMILARS AND FROM THE ORIGINATOR ADALIMUMAB TO BIOSIMILARS IN INFLAMMATORY BOWEL DISEASE PATIENTS - A MULTICENTRE STUDY ON EFFICACY AND DRUG SUSTAINABILITY
    Lontai, Livia
    Gonczi, Lorant
    Balogh, Fruzsina
    Komlodi, Nora
    Resal, Tamas
    Farkas, Klaudia
    Molnar, Tamas
    Miheller, Pal
    Golovics, Petra A.
    Schafer, Eszter
    Szamosi, Tamas
    Ilias, Akos
    Lakatos, Peter L.
    GASTROENTEROLOGY, 2022, 162 (07) : S606 - S606
  • [28] Non-medical switch between adalimumab biosimilars and from the originator adalimumab to biosimilars in inflammatory bowel disease patients - a multicentre study on efficacy and drug sustainability
    Lontai, L.
    Gonczi, L.
    Balogh, F.
    Komlodi, N.
    Resal, T.
    Farkas, K.
    Molnar, T.
    Golovics, P.
    Schafer, E.
    Szamosi, T.
    Miheller, P.
    Ilias, A.
    Lakatos, P. L.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I518 - I519
  • [29] Similar Growth Outcomes in Children with Inflammatory Bowel Disease Initiated on Infliximab Originator or Biosimilar
    Mcclinchie, Madeline G.
    Lakhani, Alyshah
    Abdel-Rasoul, Mahmoud
    Mcnicol, Megan
    Shkhkhalil, Ala K.
    Boyle, Brendan B.
    Maltz, Ross M.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2023, 77 (04): : 499 - 504
  • [30] Clinical efficacy and nocebo effect following non-medical biosimilar switch in patients with inflammatory bowel disease: A prospective observational study
    Wetwittayakhlang, Panu
    Karkout, Khaled
    Wongcha-um, Arti
    Tselekouni, Paraskevi
    Al-Jabri, Reem
    Afif, Waqqas
    Wild, Gary
    Bitton, Alain
    Bessissow, Talat
    Lakatos, Peter L.
    DIGESTIVE AND LIVER DISEASE, 2024, 56 (01) : 35 - 42
12345